CERE
KBC Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,114
| Closed | -$86K | – | 1859 |
|
|
2024
Q2 | $86K | Buy |
2,114
+569
| +37% | +$23.1K | ﹤0.01% | 1261 |
|
|
2024
Q1 | $65K | Sell |
1,545
-523
| -25% | -$22K | ﹤0.01% | 1389 |
|
|
2023
Q4 | $88K | Buy |
2,068
+953
| +85% | +$40.6K | ﹤0.01% | 1135 |
|
|
2023
Q3 | $24K | Buy |
+1,115
| New | +$24K | ﹤0.01% | 1860 |
|